Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.

Helicobacter - 1 Apr 2016

Zhou Liya, Zhang Jianzhong, Song Zhiqiang, He Lihua, Li Yanqing, Qian Jiaming, Bai Peng, Xue Yan, Wang Ye, Lin Sanren

Abstract excerpt

BACKGROUND: With markedly increased antibiotic resistance and unsatisfactory efficacies of common empiric eradication regimens in the mainland of China, tailored therapy may be the best choice to achieve good efficacy. This study compared the eradication rates, safety, and compliance of tailored therapy to those of triple therapy plus bismuth and concomitant therapy in the naïve patients with Helicobacter pylori...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clarithromycin
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disk Diffusion Antimicrobial Tests

Share to Drug Therapy, Combination

Share to Helicobacter Infections

Share to Helicobacter pylori

Share to Metronidazole

Share to Tertiary Care Centers

Source

Identifiers

PMID: 26104022
DOI: 10.1111/hel.12242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.PMID 26104022Read ↗

Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.Semantic proximity Read ↗

Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K-CREATE Study.Semantic proximity Read ↗

[Minocycline quadruple versus tailored therapy in retreatment of Helicobacter pylori infection].Semantic proximity Read ↗

Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.Semantic proximity Read ↗

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.Semantic proximity Read ↗

Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.Semantic proximity Read ↗

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.Semantic proximity Read ↗

Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Semantic proximity Read ↗

Optimizing the Routine Use of Clinical Guidelines by Addition of Supplements (Probiotics and/or Bismuth) to <em>Helicobacter pylori</em> Eradication Protocols in a Clarithromycin Resistant and Tetracycline/Bismuth Naive Area: A Real-World Data Retrospective Analys of 402 Cases (2016-24) in a Single Gastroenterology UnitSemantic proximity Read ↗

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Semantic proximity Read ↗

Attempts to enhance the eradication rate of Helicobacter pylori infection.Semantic proximity Read ↗

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.